FDA backs Vytorin for kidney disease patients (AP)
AP – The Food and Drug Administration says Merck’s cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.
View full post on Yahoo! News: Health News
Leave a Reply